Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CCR2 | P41597 | 1/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1410774 | 0.76 | GRM2 (0.41) | KEAP1NFE2L2ALDH1A1TSHRCCR2 | |
| SCHEMBL432459 | 0.76 | CCR2 (0.37) | KEAP1NFE2L2ALDH1A1TSHRCCR2 | |
| SCHEMBL28057200 | 0.75 | KEAP1 (0.39) | KEAP1NFE2L2ALDH1A1GRM2GRM3 | |
| SCHEMBL6282906 | 0.75 | KEAP1 (0.39) | KEAP1NFE2L2ALDH1A1GRM2GRM3 | |
| SCHEMBL11351080 | 0.74 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL10617618 | 0.73 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL3013647 | 0.72 | KEAP1 (0.37) | KEAP1NFE2L2ALDH1A1GRM2GRM3 | |
| SCHEMBL1793441 | 0.70 | ALDH1A1 (0.31) | ALDH1A1TSHRCCR2CASP1 | |
| SCHEMBL18285638 | 0.69 | — | — | |
| SCHEMBL11812881 | 0.69 | CYP1A2 (0.39) | KEAP1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3684898-B1 | METHOD FOR PRODUCING AN ACTIVE SUBSTANCE WAFER | SYMRISE AG (DE) | 2025-04-30 | — | — | EP | disclosed |
| US-20220411728-A1 | HOME CARE PRODUCT OR FORMULATION | SYMRISE AG (DE) | 2022-12-29 | — | — | US | disclosed |
| US-11512267-B2 | Active substance wafer | SYMRISE AG (DE) | 2022-11-29 | — | — | US | disclosed |
| EP-4061915-A1 | HOME CARE PRODUCT OR FORMULATION | Symrise AG (DE) | 2022-09-28 | — | — | EP | disclosed |
| WO-2022124003-A1 | FRAGRANCE COMPOSITION | 花王株式会社 | 2022-06-16 | — | — | WO | disclosed |
| CN-114585715-A | Home care products or formulations | 西姆莱斯有限公司 | 2022-06-03 | — | — | CN | disclosed |
| WO-2021098950-A1 | HOME CARE PRODUCT OR FORMULATION | SYMRISE AG (DE) | 2021-05-27 | — | — | WO | disclosed |
| EP-3740556-A1 | TRANSPARENT ACTIVE SUBSTANCE RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME | Symrise AG (DE) | 2020-11-25 | — | — | EP | disclosed |
| EP-3737428-A1 | ARTICLE PROVIDING SELECTIVE INTERCONNECTIVITY OF CARRIER MATERIALS COMPRISING FRAGRANCES | Symrise AG (DE) | 2020-11-18 | — | — | EP | disclosed |
| EP-3737427-A1 | ARTICLE WITH SEPARATING LAYER FOR CONTROLLED RELEASE OF FRAGRANCES | Symrise AG (DE) | 2020-11-18 | — | — | EP | disclosed |
| EP-3684898-A1 | ACTIVE SUBSTANCE WAFER | Symrise AG (DE) | 2020-07-29 | — | — | EP | disclosed |
| US-20200216782-A1 | ACTIVE SUBSTANCE WAFER | SYMRISE AG (DE) | 2020-07-09 | — | — | US | disclosed |
| WO-2019057294-A1 | ACTIVE SUBSTANCE WAFER | SYMRISE AG (DE) | 2019-03-28 | — | — | WO | disclosed |
| US-8513180-B2 | Ethanol-free perfume oil microemulsion | SYMRISE AG (DE) | 2013-08-20 | — | — | US | disclosed |
| US-20120101020-A1 | ETHANOL-FREE PERFUME OIL MICROEMULSION | SYMRISE AG (DE) | 2012-04-26 | — | — | US | disclosed |
| US-20090123392-A1 | FRAGRANCE ACCORDS TO COMBAT THE PERCEPTION OF BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-05-14 | — | — | US | disclosed |
| US-20070298994-A1 | Use of 3-Mercapto-3-Methyl-Hexan-1-Ol for Use as Malodour Standard | SYMRISE GMBH & CO. KG (DE) | 2007-12-27 | — | — | US | disclosed |
| EP-1029841-B1 | 6-Substituted 3-methyloct-6-enols | GIVAUDAN SA (CH) | 2003-04-09 | — | — | EP | disclosed |
| US-6297211-B1 | PERFUMES AND BRANCHED UNSATURATED ALCOHOLS | GIVAUDAN ROURE (INTERNATIONAL) SA (CH) | 2001-10-02 | — | — | US | disclosed |
| EP-1029841-A1 | 6-Substituted 3-methyloct-6-enols | Givaudan Roure (International) S.A. (CH) | 2000-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101020-A1 | ETHANOL-FREE PERFUME OIL MICROEMULSION | FFAR2, FFAR3, FFAR1 | KEAP1 3895/4885NFE2L2 1474/4885ALDH1A1 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.